PLEKHA5 and neoplasm: The detection of markers suchas PLEKHA5 and NDRG1 in primary tumour biopsies could provide an earlyindication of aggressive phenotype, providing they can be fully validated.Practical limitations on prognostic biomarker translation are expertly reviewedelsewhere [32,33].